The growing emergence of antimicrobial resistance represents a global problem that not
only influences healthcare systems but also has grave implications for political and …

Biofilm-associated infections pose a complex problem to the medical community, in that
residence within the protection of a biofilm affords pathogens greatly increased tolerances to …

Biofilms are aggregate of microorganisms in which cells are frequently embedded within a
self-produced matrix of extracellular polymeric substance (EPS) and adhere to each other …

We investigated genomic diversity of a yeast species that is both an opportunistic pathogen
and an important industrial yeast. Under the name Candida krusei, it is responsible for about …

Antimicrobial peptides (AMPs) have recently attracted a great deal of attention as promising
antibiotic candidates, but some obstacles such as toxicity and high synthesis cost must be …

The incidence of invasive fungal infections is increasing worldwide, resulting in more than
1.6 million deaths every year. Due to growing antifungal drug resistance and the limited …

Most antifungal peptides (AFPs), if not all, have membrane activity, while some also have
alternative targets. Fungal membranes share many characteristics with mammalian …

Infectious diseases caused by bacteria, viruses or fungi are among the leading causes of
death worldwide. The emergence of drug-resistance mechanisms, especially among …

Mycoses are accountable for millions of infections yearly worldwide. Invasive candidiasis is
the most usual, presenting a high morbidity and mortality. Candida albicans remains the …

Candida auris, an evolving multidrug-resistant pathogenic yeast, is known for causing
severe invasive infections associated with high mortality rates in hospitalized individuals …